Skip to main content
PolicySpeak
← All files
TUR

Tampere University Regea Cell and Tissue Center

Academic / research · Finland · EU Transparency Register 699681335670-44

2
positions filed
in the 583 files tracked
1
legislative file
of 583 tracked
0
with a full position paper
attached to a submission

Counts here are a floor, never a total: they cover the 583 consultation files tracked so far (42,224 submissions, mostly 2025–26), so an organization's real filing history is larger, not smaller.

Who they are

Among the 49 academic institutions on this site, they rank #28 by legislative files engaged — a count of participation, not a measure of influence.

0.2
declared lobbying FTE
self-declared
< €10K
declared costs / yr (floor)
0
EP accreditations
as declared to the register
2019
in the register since
Register category
Academic institutions
Registered as
Tampere University (TUNI)
Head office
Tampere University, Finland

Self-declared to the EU Transparency Register (snapshot 2 Sept 2026); cost bands are floors, not audited totals. Reused under Commission Decision 2011/833/EU.

Track Tampere in PolicySpeak: request access →

Work at Tampere University Regea Cell and Tissue Center? so we know who speaks for it.

Follow the file Tampere University Regea Cell and Tissue Center engages with

One email on Tuesdays when a new position is filed on this file, from Tampere University Regea Cell and Tissue Center or from anyone else on it. Only when there is something new.

We use your email for these updates, and PolicySpeak may contact you about the product. Unsubscribe in one click. Privacy policy.

Their record over time

Tampere University Regea Cell and Tissue Center filed 2 positions between 14 Dec 2020 and 8 Sept 2022, across 1 of the 583 legislative files tracked here.

2020 · 1 filed2022 · 1 filed

What they argued

Standards of quality and safety for substances of human origin intended for human applicationfiled 8 Sept 2022source

We welcome the Commission proposal for an EU regulation on standards of quality and safety for substances of human origin (SoHO) intended for human application (2022/0216). Regarding the choice of the legal instruments, the implementation of a single Regulation that will directly apply in all member states and the possibility to use EDQM and ECDC guidelines for more efficient updating of the technical requirements…

Looking for an argument rather than an organization? Search every submission for a phrase and see everyone who used it.

Put Tampere University Regea Cell and Tissue Center next to another organization. Same files, same register facts, side by side. Compare →

Is this your organization?

Everything on this page comes from Tampere University Regea Cell and Tissue Center’s own submissions to the European Commission — we have added nothing and interpreted nothing. If something is wrong or out of date, email info@policyspeak.com and we will correct it. If you are an individual named in a record, our privacy policy sets out your rights to correction, objection and removal.

Quotes are verbatim from submissions published by the European Commission, trimmed to their opening passage and never summarized by a model. Organizations only, never individuals. Reused under Commission Decision 2011/833/EU; the European Commission is not liable for this reuse.